Methods of detection of first recurrence in patients with stage I/II primary cutaneous melanoma after sentinel lymph node biopsy

Annals of Surgical Oncology

Volumn 15, Issue 8, 2008, Pages 2206-2214

  Moore Dalal, Kimberly ^a,b,c   Zhou, Qin ^c   Panageas, Katherine S ^c   Brady, Mary S ^c   Jaques, David P ^c,d   Coit, Daniel G ^c  

^a DAVID GRANT MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d WASHINGTON UNIVERSITY   (United States)

Author keywords

Detection; Melanoma; Patient education; Recurrence

Indexed keywords

LACTATE DEHYDROGENASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MELANOMA; POSITRON EMISSION TOMOGRAPHY; PRIMARY CUTANEOUS MELANOMA; SELF EXAMINATION; SENTINEL LYMPH NODE BIOPSY; SYMPTOM; THORAX RADIOGRAPHY; TUMOR LOCALIZATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; SENTINEL LYMPH NODE BIOPSY; SKIN NEOPLASMS;

EID: 48149106173     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-008-9985-z     Document Type: Article

References (35)

1. CM Balch AC Buzaid SJ Soong 2001 Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma J Clin Oncol 19 3635 48
2. AB Francken E Bastiaannet HJ Hoekstra 2005 Follow-up in patients with localised primary cutaneous melanoma Lancet Oncol 6 608 21
3. A Jemal R Siegel E Ward 2007 Cancer Statistics, 2007 CA Cancer J Clin 57 43 66
4. DL Morton DR Wen JH Wong 1992 Technical details of intraoperative lymphatic mapping for early stage melanoma Arch Surg 127 392 9
5. JE Gershenwald W Thompson PF Mansfield 1999 Multi-institutional melanoma lymphatic mapping experience: the prognostic value of sentinel lymph node status in 612 stage I or II melanoma patients J Clin Oncol 17 976 83
6. Stadelmann W, Rapaport D, Soong S, et al. Prognostic clinical and pathologic features. 3rd edition. St. Louis: Quality Medical, 1998
7. BM Clary MS Brady JJ Lewis 2001 Sentinel lymph node biopsy in the management of patients with primary cutaneous melanoma: review of a large single-institutional experience with an emphasis on recurrence Ann Surg 233 250 8
8. JE Gershenwald MI Colome JE Lee 1998 Patterns of recurrence following a negative sentinel lymph node biopsy in 243 patients with stage I or II melanoma J Clin Oncol 16 2253 60
9. MA Gadd DG Coit 1992 Recurrence patterns and outcome in 1019 patients undergoing axillary or inguinal lymphadenectomy for melanoma Arch Surg 127 1412 6
10. KM Dalal A Patel MS Brady 2007 Patterns of first recurrence and post-recurrence survival in patients with primary cutaneous melanoma after sentinel lymph node biopsy Ann Surg Oncol 14 1934 42
11. DS Rigel RJ Friedman AQ Kopf 1996 The incidence of malignant melanoma in the United States: issues as we approach the 21st century J Am Acad Dermatol 34 839 47
12. CR Shumate MM Urist WA Maddox 1995 Melanoma recurrence surveillance Ann Surg 221 566 9
13. CA Baughan VL Hall BJ Leppard 1993 Follow-up in stage I cutaneous malignant melanoma: an audit Clin Oncol 5 174 80
14. M Weiss CL Loprinzi ET Creagan 1995 Utility of follow-up tests for detecting recurrence disease in patients with malignant melanoma JAMA 274 1703 5
15. U Hofmann M Szedlak W Rittgen 2002 Primary staging and follow-up in melanoma patients-monocenter evaulation of methods, costs, and patient survival Br J Cancer 87 151 7
16. JD Wagner MS Gordon TY Chuang 2000 Predicting sentinel and residual lymph node basin disease after sentinel lymph node biopsy for melanoma Cancer 89 453 62
17. WJ Poo-Hwu S Ariyan L Lamb 1999 Follow-up recommendations for patients with American Joint Committee on Cancer Stages I-III malignant melanoma Cancer 86 2252 8
18. R Essner JH Lee LA Wanek 2004 Contemporary surgical treatment of advanced-stage melanoma Arch Surg 139 961 6
19. H Tsao M Feldman JF Fullerton 2004 Early detection of asymptomatic pulmonary melanoma metastases by routine chest radiographs is not associated with improved survival Arch Dermatol 140 67 70
20. A Brobeil D Rapaport K Wells 1997 Multiple primary melanomas: implications for screening and follow-up programs for melanoma Ann Surg Oncol 4 19 23
21. C Garbe A Paul H Kohler-Spath 2003 Prospective evaluation of a follow-up schedule in cutaneous melanoma patients: recommendations for an effective follow-up strategy J Clin Oncol 21 520 9
22. CR Ferrone L Ben Porat KS Panageas 2005 Clinicopathological features of and risk factors for multiple primary melanomas JAMA 294 1647 54
23. PE Schofield LJ Beeney JF Thompson 2001 Hearing the bad news of a cancer diagnosis: the Australian melanoma patient's perspective Ann Oncol 12 365 71
24. WB Goggins H Tsao 2003 A population-based analysis of risk factors for a second primary cutaneous melanoma among melanoma survivors Cancer 97 639 43
25. TM Johnson T Hamilton L Lowe 1998 Multiple primary melanomas J Am Acad Dermatol 39 422 7
26. S Kang RI Barnhill MR Mihm Jr 1992 Multiple primary cutaneous melanomas Cancer 70 1911 6
27. Y Brandberg E Mansson-Brahme U Ringborg 1995 Psychological reactions in patients with malignant melanoma Eur J Cancer 31 157 62
28. MM Mooney M Kulas B McKinley 1998 Impact on survival by method of recurrence detection in stage I and II cutaneous melanoma Ann Surg Oncol 5 54 63
29. MM Mooney C Mettline Am Michalek 1997 Life-long screening of patients with intermediate-thickness cutaneous melanoma for asymptomatic pumonary recurrences: a cost-effectiveness analysis Cancer 80 1052 64
30. NCCN. (2006) Melanoma. Clinical Practice Guidelines in Oncology, volume 2. pp 1-33
31. M del Rosselli Truco D Palli A Cariddi 1994 Intensive diagnostic follow-up after treatment of primary breast cancer: a randomized trial. National Research Council Project on Breast Cancer follow-up JAMA 271 1593 7
32. PA Kersey NA Iscoe JA Gapski 1985 The value of staging and serial follow-up investigations in patients with completely resected, primary, cutaneous malignant melanoma Br J Surg 72 614 7
33. MW Regan C Reid RW Griffiths 1985 Malignant melanoma evaluation of clinical follow-up by questionnaire survey Br J Plast Surg 38 11 14
34. N Basseres JJ Grob MA Richard 1995 Cost-effectiveness of surveillance of stage I melanoma: a retrospective appraisal based on a 10-year experience in a dermatology department in France Dermatology 191 199 203
35. TJ Dicker G Kavanagh RM Herd 1999 A rational approach to melanoma follow-up in patients with primary cutaneous melanoma Br J Dermatol 140 249 54